3Nadler G,Delimoge I.Stereospecificity of myofibrillar [4-(sub-stituted-amino)phenyl] calcium sen-sitivity and PDE inhibition in cardiotonic thiadiazinones [ J ].Eur J Med Chem,1996,31(10):805-812.
4Endoh M.Mechanisms of action of novel cardiotonic agents[J].J Cardiovasc Pharmacol,2002,40 (3):323-328.
5Hasenfus G.Effects of calcium sensitizer on intracellular calcium handing and myocardial energyetics [ J ].J Cardiovasc pharmacol,1995,261:45-51.
6Brixius K,Hoischen S,Zobel C,et al.The Ca^2+sensitizers 0GP48506and EMD-57O33,but not the Na^+channel modulator BDF 9148,prolong contractile twitch in guine pig cardiomyocyte[J].ZKardiol,2001,90(4):286-291.
7Duncker DJ,Haitsma DB,Liem DA,et al.Beneficial effects of the Ca^2+sensitizer EMD-57033 in exercising pigs with infraction-induced chronic left ventricular dysfunction [J ].Br J Phmarmacol,2001,134(3):553-556.
8Takaoka H,Takeuchi M,Hata K,et al.Beneficial effects of a Ca^2+sensitizer,MCI-154,on the myocardial oxygen consumption cardiac output relation in patients with left ventricular dysfunction after,myocardial infarction:compartion with dobutamine and phosphodiesterase inhibitor[J].Am Heart J,1997,133(3):283-289.
9Narimatsu A,Kitada Y,Satoh N,et al.In vitro characterczation of the effects of MCI-154,a novel cardiotonic agent,on cardiac tissues[J].Jpn J Pharmacol,1989,49(3):397-405.
